These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30456450)

  • 1. Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma.
    Ma B; Chen K; Liu P; Li M; Liu J; Sideras K; Sprengers D; Biermann K; Wang W; IJzermans JNM; Cao W; Kwekkeboom J; Peppelenbosch MP; Pan Q
    J Mol Med (Berl); 2019 Jan; 97(1):77-88. PubMed ID: 30456450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
    Yang Z; Meng Q; Zhao Y; Han R; Huang S; Li M; Wu X; Cai W; Wang H
    J Interferon Cytokine Res; 2018 Jun; 38(6):261-271. PubMed ID: 29762078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.
    Li T; Dong ZR; Guo ZY; Wang CH; Tang ZY; Qu SF; Chen ZT; Li XW; Zhi XT
    Cancer Gene Ther; 2013 Jun; 20(6):366-74. PubMed ID: 23703473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
    Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
    Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
    Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.
    Ding H; Liu J; Liu B; Zeng Y; Chen P; Su Y
    Biochem Biophys Res Commun; 2018 Jun; 500(4):973-980. PubMed ID: 29715456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.
    Inamura K; Matsuzaki Y; Uematsu N; Honda A; Tanaka N; Uchida K
    Biochim Biophys Acta; 2005 Sep; 1745(3):401-10. PubMed ID: 16054712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
    Michalska A; Blaszczyk K; Wesoly J; Bluyssen HAR
    Front Immunol; 2018; 9():1135. PubMed ID: 29892288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.
    Sung PS; Cheon H; Cho CH; Hong SH; Park DY; Seo HI; Park SH; Yoon SK; Stark GR; Shin EC
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10443-8. PubMed ID: 26216956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma.
    Yang Y; Zhou Y; Hou J; Bai C; Li Z; Fan J; Ng IOL; Zhou W; Sun H; Dong Q; Lee JMF; Lo CM; Man K; Yang Y; Li N; Ding G; Yu Y; Cao X
    Hepatology; 2017 Jul; 66(1):152-166. PubMed ID: 28295457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.
    Jilg N; Lin W; Hong J; Schaefer EA; Wolski D; Meixong J; Goto K; Brisac C; Chusri P; Fusco DN; Chevaliez S; Luther J; Kumthip K; Urban TJ; Peng LF; Lauer GM; Chung RT
    Hepatology; 2014 Apr; 59(4):1250-61. PubMed ID: 23913866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).
    Chen Y; Fu H; Zhang Y; Chen P
    Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper-activated IRF-1 and STAT1 contribute to enhanced interferon stimulated gene (ISG) expression by interferon alpha and gamma co-treatment in human hepatoma cells.
    Zhang XN; Liu JX; Hu YW; Chen H; Yuan ZH
    Biochim Biophys Acta; 2006; 1759(8-9):417-25. PubMed ID: 16987558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.
    Ichikawa T; Nakao K; Nakata K; Yamashita M; Hamasaki K; Shigeno M; Abiru S; Ishikawa H; Ishii N; Eguchi K
    Biochem Biophys Res Commun; 2002 Jun; 294(2):414-22. PubMed ID: 12051728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells.
    Zhao LJ; Hua X; He SF; Ren H; Qi ZT
    Virol J; 2011 Apr; 8():157. PubMed ID: 21466707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells.
    Li W; Huang X; Tong H; Wang Y; Zhang T; Wang W; Dai L; Li T; Lin S; Wu H
    PLoS One; 2012; 7(10):e47040. PubMed ID: 23056571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
    He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
    Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.